Aethlon Medical Files 8-K
Ticker: AEMD · Form: 8-K · Filed: Aug 12, 2024 · CIK: 882291
| Field | Detail |
|---|---|
| Company | Aethlon Medical Inc (AEMD) |
| Form Type | 8-K |
| Filed Date | Aug 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, filing, corporate-update
Related Tickers: AETH
TL;DR
AETH filed an 8-K on 8/12/24 - check for updates.
AI Summary
Aethlon Medical, Inc. filed an 8-K on August 12, 2024, reporting other events and financial statements/exhibits. The company, incorporated in Nevada, is based in San Diego, California, and operates in the surgical and medical instruments sector. This filing does not detail specific transactions or financial figures but serves as a notification of events and accompanying documents.
Why It Matters
This 8-K filing indicates that Aethlon Medical, Inc. has submitted important corporate updates and financial information to the SEC, which could contain material developments for investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and 'Financial Statements and Exhibits' without specific transactional details, suggesting it's procedural rather than indicative of a major event.
Key Players & Entities
- Aethlon Medical, Inc. (company) — Registrant
- August 12, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- San Diego, California (location) — Principal executive offices
- 3841 (sic_code) — Standard Industrial Classification
FAQ
What specific 'Other Events' are being reported by Aethlon Medical, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the 'Other Events' being reported; it only lists the item category.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported is August 12, 2024.
In which U.S. state is Aethlon Medical, Inc. incorporated?
Aethlon Medical, Inc. is incorporated in Nevada.
What is the Standard Industrial Classification (SIC) code for Aethlon Medical, Inc.?
The SIC code for Aethlon Medical, Inc. is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
What is the company's principal executive office address?
The company's principal executive offices are located at 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121.
Filing Stats: 468 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-08-12 08:01:08
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share AEMD The Nasdaq
Filing Documents
- aethlon_8k.htm (8-K) — 25KB
- aethlon_ex9901.htm (EX-99.1) — 13KB
- aethlonlogo.jpg (GRAPHIC) — 9KB
- 0001683168-24-005445.txt ( ) — 225KB
- aemd-20240812.xsd (EX-101.SCH) — 3KB
- aemd-20240812_lab.xml (EX-101.LAB) — 33KB
- aemd-20240812_pre.xml (EX-101.PRE) — 22KB
- aethlon_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On August 12, 2024, Aethlon Medical, Inc. (the "Company") issued a press release announcing that the Bellberry Human Research Ethics Committee has granted full ethics approval to the Pindara Private Hospital for a safety, feasibility and dose-finding clinical trial for the Company's Hemopurifier in patients with solid tumors not responding to anti-PD-1 antibodies. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.
01 Financial
Item 9.01 Financial (d) Exhibits Exhibit Number Description 99.1 Press Release, dated August 12, 2024 104 Cover Page Interactive Data File (embedded within the inline XBRL Document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 12, 2024 Aethlon Medical, Inc. By: /s/ James B. Frakes Name: James B. Frakes Interim Chief Executive Officer and Chief Financial Officer 2